This phenomenon is highly important in CLL given the indolent nature of this cancer, which allows prolonged interactions of malignant B cells with immune cells (e.g., cytotoxic CD8+ T cells). The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.